Antineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsDrug Screening Assays, AntitumorCell Line, TumorChemotherapy, AdjuvantXenograft Model Antitumor AssaysRadiation DosageRadiation, IonizingDoxorubicinNeoplasmsCisplatinMice, NudeCombined Modality TherapyRadiation InjuriesApoptosisAntibiotics, AntineoplasticDose-Response Relationship, RadiationNeoplasm TransplantationRadiation ToleranceTumor Cells, CulturedAntineoplastic Agents, PhytogenicDrug Resistance, NeoplasmNeoplasms, ExperimentalCyclophosphamideRadiationDrug SynergismBreast NeoplasmsTreatment OutcomeCell SurvivalLung NeoplasmsPaclitaxelEtoposideMelanoma, ExperimentalCell ProliferationMice, Inbred BALB CRadiation ProtectionDose-Response Relationship, DrugRadiation MonitoringSarcoma 180Leukemia P388CamptothecinDrug Administration ScheduleDrug Delivery SystemsColonic NeoplasmsAntineoplastic Agents, AlkylatingTransplantation, HeterologousSurvival AnalysisTime FactorsImmunotherapyDisease-Free SurvivalAntimetabolites, AntineoplasticMice, Inbred C57BLDrug CarriersMice, SCIDAntibodies, MonoclonalAdenocarcinomaRadiotherapyVinblastineOrganoplatinum CompoundsTumor BurdenGenetic TherapySurvival RateNeoadjuvant TherapyTaxoidsCancer VaccinesNeoplasm StagingRadiation-Sensitizing AgentsMethotrexateAngiogenesis InhibitorsBrain NeoplasmsOvarian NeoplasmsBleomycinDeoxycytidinePrognosisInhibitory Concentration 50Radiation OncologyCell DivisionCarboplatinRadiotherapy DosageCell CycleLeukemia L1210Carcinoma, Lewis LungDNA DamageNeoplasm MetastasisProdrugsGene Expression Regulation, NeoplasticLiver NeoplasmsNeovascularization, PathologicMelanomaMitomycinFlow CytometryCarcinoma, Non-Small-Cell LungFibrosarcomaNeoplasm Recurrence, LocalInjections, IntralesionalEllipticinesGamma RaysAdenoviridaeOncolytic VirotherapyCarcinoma, Squamous Cell